mutations
UNMC scientists use new technology to discover SARS-CoV-2 mutations in Nebraska
Scientists at the Nebraska Public Health Laboratory have found mutations to the novel coronavirus using new technology that allows the state to track COVID-19 across Nebraska more precisely. The technology enables scientists to conduct a new kind of whole gene sequencing that helps officials confirm whether cases of COVID-19 reinfection come from the same clone …
What do studies on new coronavirus mutations tell us?
LONDON (Reuters) – A series of studies of the genomes of thousands of samples of the new coronavirus SARS-CoV-2 show that it is mutating and evolving as it adapts to its human hosts. FILE PHOTO: The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), which was identified as the cause of an outbreak of …
Scientists develop a new gene-editing tool that could help treat many disorders caused by gene mutations — ScienceDaily
The ability to edit genes in living organisms offers the opportunity to treat a plethora of inherited diseases. However, many types of gene-editing tools are unable to target critical areas of DNA, and creating such a technology has been difficult as living tissue contains diverse types of cells. Now, Salk Institute researchers have developed a …
A novel technology for genome-editing a broad range of mutations in live organisms
LA JOLLA–(August 23, 2019) The ability to edit genes in living organisms offers the opportunity to treat a plethora of inherited diseases. However, many types of gene-editing tools are unable to target critical areas of DNA, and creating such a technology has been difficult as living tissue contains diverse types of cells. Now, Salk Institute …
More women should be assessed for BRCA mutations, new recommendations say
ATLANTA (CNN) — More women should be assessed for harmful mutations in the BRCA1 and BRCA2 genes that can increase risk of certain cancers, according to new recommendations. Previously, it was recommended for women who have a family history of breast, ovarian, tubal or peritoneal cancer to be assessed for harmful BRCA1 or BRCA2 mutations. …